INTRODUCTION: The French guidelines on the management of benign prostatic hyperplasia (BPH) have been published in 2012 by the LUTS committee of the French Urological Association.
The aim of this study was to evaluate the impact of these guidelines on the BPH management by French urologists.
MATERIAL AND METHODS: A questionnaire has been distributed by email to 1141 urologists members of the French Association of Urologists in November 2013.
RESULTS: We collected 222 responses (response rate: 19%). The guidelines have been read by 73% of the urologists. The guidelines were followed most of the time by 76% of them, 11% followed them systematically and 4.5% did not follow them. The new terminology was used by 28 to 52% according to the items. The symptoms were evaluated by the IPSS score (33%), by interrogatory alone (64%) or by neither of them (3%). Prostate volume was not systematically taken for account in the treatment strategy by 57% of the urologists. Sexual function was assessed systematically by 28% of the urologists, 11% used a questionnaire (IIEF: 92%). PSA was tested respectively by 70 and 51% of the urologists at the initial evaluation and the follow-up. After introduction of a monotherapy, 56% of the urologists evaluated the efficacy at 3 months.
CONCLUSION: The French guidelines for the management of benign prostatic hyperplasia (BPH) by the LUTS committee of the French Urological Association were well known and used by French urologists. Some improvements can be expected for the use of the IPSS score, the evaluation of the sexual function, and the use of the new terminology.
Written by:
Lebdai S, Rahmène Azzouzi A, Delongchamps NB, Benchikh A, Campeggi A, Cornu JN, Dumonceau O, Faix A, Fourmarier M, Haillot O, Lukacs B, Mathieu R, Misrai V, Robert G, de La Taille A, Descazeaud A. Are you the author?
Service d'urologie, CHU d'Angers, 4, rue Larrey, 49933 Angers cedex 9, France; Service d'urologie, CHU Cochin, 75014 Paris, France; Service d'urologie, hôpital Bichat - Claude-Bernard, groupe des hôpitaux universitaires Paris-Nord-Val-de-Seine, université Denis-Diderot, Paris-VII, 75018 Paris, France; Service d'urologie, CHU Mondor, 75000 Paris, France; Service d'urologie, hôpital Tenon, Assistance publique-Hôpitaux de Paris, université Pierre-et-Marie-Curie - Paris-6, 75020 Paris, France; Service d'urologie, clinique Turin, 75008 Paris, France; Clinique mutualiste Beausoleil, 34070 Montpellier, France; Service d'urologie, centre hospitalier d'Aix-en-Provence, 13616 Aix-en-Provence, France; Service d'urologie, CHU de Tours, 37044 Tours, France; Service d'urologie, hôpital Pontchaillou, CHU de Rennes, 35000 Rennes, France; Service d'urologie, clinique Pasteur, 31300 Toulouse, France; Service d'urologie, CHU de Bordeaux, université Bordeaux-Segalen, 33076 Bordeaux, France; Service de chirurgie urologique, CHU de Limoges, 87042 Limoges, France.
Reference: Prog Urol. 2015 Jan;25(1):47-53.
doi: 10.1016/j.purol.2014.09.049
PubMed Abstract
PMID: 25453357
Article in French.